COVID-19 pneumonia treated with Sarilumab: A clinical series of eight patients
J Med Virol
.
2020 Nov;92(11):2368-2370.
doi: 10.1002/jmv.26062.
Epub 2020 Jun 16.
Authors
Maurizio Benucci
1
,
Gianfranco Giannasi
2
,
Paolo Cecchini
2
,
Francesca Li Gobbi
1
,
Arianna Damiani
3
,
Valentina Grossi
4
,
Maria Infantino
4
,
Mariangela Manfredi
4
Affiliations
1
Department of Internal Medicine, Rheumatology Unit, Azienda USL-Toscana Centro, Hospital San Giovanni di Dio, Florence, Italy.
2
Emergency Department and Covid Unit, Azienda USL-Toscana Centro, Hospital San Giovanni di Dio, Florence, Italy.
3
Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.
4
Department of laboratory, Immunology and Allergology Laboratory, Azienda USL-Toscana Centro, Hospital San Giovanni di Dio, Florence, Italy.
PMID:
32472703
PMCID:
PMC7300861
DOI:
10.1002/jmv.26062
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
COVID-19*
Humans
SARS-CoV-2
Treatment Outcome
Substances
Antibodies, Monoclonal, Humanized
tocilizumab
sarilumab